Lon Cardon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Reneo Pharmaceuticals, Inc., and Mirum Pharmaceuticals, Inc..

2024 was Lon Cardon's most active year for acquiring shares with 2 total transactions. Lon Cardon's most active month to acquire stocks was the month of May. 2022 saw Lon Cardon paying a total of $0.00 for 34,000 shares, this is the most they've acquired in one year.